LENZ
LENZ Therapeutics, Inc.Company with tickers: LENZ
CIK
1815776
CUSIP
52635N103
Shares Outstanding
31,354,394
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-27 | George Jeffrey P. | Director | Buy | 5,592 |
| 2026-03-27 | Schimmelpennink Evert B. | Director | Buy | 28,089 |
| 2026-03-27 | Chevallard Daniel R. | Chief Financial Officer | Buy | 7,500 |
| 2026-01-02 | Olsson Shawn | Chief Commercial Officer | Award | 84,200 |
| 2026-01-02 | Olsson Shawn | Chief Commercial Officer | Award | 14,000 |
| 2026-01-02 | Schimmelpennink Evert B. | Director | Award | 358,100 |
| 2026-01-02 | Odrich Marc | Chief Medical Officer | Award | 14,000 |
| 2026-01-02 | Odrich Marc | Chief Medical Officer | Award | 84,200 |
| 2026-01-02 | Chevallard Daniel R. | Chief Financial Officer | Award | 84,200 |
| 2026-01-02 | Chevallard Daniel R. | Chief Financial Officer | Award | 14,000 |
| 2025-11-17 | Olsson Shawn | Chief Commercial Officer | Sell | 5,788 |
| 2025-11-17 | Olsson Shawn | Chief Commercial Officer | Convert | 10,000 |
| 2025-11-17 | Olsson Shawn | Chief Commercial Officer | Sell | 4,212 |
| 2025-11-17 | Olsson Shawn | Chief Commercial Officer | Convert | 10,000 |
| 2025-11-07 | Chevallard Daniel R. | Chief Financial Officer | Buy | 20 |
| 2025-11-07 | Chevallard Daniel R. | Chief Financial Officer | Buy | 2,178 |
| 2025-11-07 | MCCOLLUM JAMES W | Director | Other | 620,599 |
| 2025-11-07 | MCCOLLUM JAMES W | Director | Buy | 10,500 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 57,502 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 83,066 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 34,405 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 177 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 49,701 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 123 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 49,479 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 132 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 24,370 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 20,148 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 40,907 |
| 2025-09-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 268 |
| 2025-08-26 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 21,661 |
| 2025-08-26 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 1,707 |
| 2025-08-26 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 3,465 |
| 2025-08-26 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 43,978 |
| 2025-08-25 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 2,149 |
| 2025-08-25 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 50,270 |
| 2025-08-25 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 24,760 |
| 2025-08-25 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 1,058 |
| 2025-08-22 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 2,809 |
| 2025-08-22 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 10,076 |
| 2025-08-22 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 5,668 |
| 2025-08-22 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 20,493 |
| 2025-08-22 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-08-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 30,628 |
| 2025-08-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 15,085 |
| 2025-08-15 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 145,051 |
| 2025-08-15 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 69,949 |
| 2025-08-15 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-07-10 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 1,047,912 |
| 2025-07-10 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-07-10 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 191,376 |
| 2025-06-27 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 1,047,912 |
| 2025-06-27 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 200,000 |
| 2025-06-27 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-06-20 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 133,924 |
| 2025-06-20 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 100,877 |
| 2025-06-18 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-06-18 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 100,000 |
| 2025-06-11 | MCCOLLUM JAMES W | Director | Award | 13,500 |
| 2025-06-11 | Drapkin Kimberlee C | Director | Award | 13,500 |
| 2025-06-11 | Guerard Frederic | Director | Award | 13,500 |
| 2025-06-11 | Thunen Shelley B | See remarks | Award | 13,500 |
| 2025-06-11 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 13,500 |
| 2025-06-11 | George Jeffrey P. | Director | Award | 13,500 |
| 2025-06-11 | Scheiner Zachary | Director | Award | 13,500 |
| 2025-06-10 | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 350,000 |
| 2025-06-10 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 2,101,199 |
| 2025-06-10 | Versant Venture Capital VI, L.P. | 10% Owner | Other | 842,162 |
| 2025-04-09 | Olsson Shawn | Chief Commercial Officer | Convert | 1,400 |
| 2025-04-09 | Olsson Shawn | Chief Commercial Officer | Convert | 1,400 |
| 2025-03-07 | Schimmelpennink Evert B. | Director | Convert | 4,200 |
| 2025-03-07 | Schimmelpennink Evert B. | Director | Convert | 4,200 |
| 2025-01-09 | Olsson Shawn | Chief Commercial Officer | Award | 80,100 |
| 2025-01-09 | Odrich Marc | Chief Medical Officer | Award | 80,100 |
| 2025-01-09 | Chevallard Daniel R. | Chief Financial Officer | Award | 70,444 |
| 2025-01-09 | Schimmelpennink Evert B. | Director | Award | 279,100 |
| 2024-12-16 | Olsson Shawn | Chief Commercial Officer | Convert | 3,333 |
| 2024-12-16 | Olsson Shawn | Chief Commercial Officer | Convert | 3,333 |
| 2024-07-22 | Schimmelpennink Evert B. | Director | Convert | 45,000 |
| 2024-07-22 | Schimmelpennink Evert B. | Director | Convert | 45,000 |
| 2024-05-14 | Chevallard Daniel R. | Chief Financial Officer | Buy | 3,188 |
| 2024-05-13 | MCCOLLUM JAMES W | Director | Other | 95,034 |
| 2024-05-13 | MCCOLLUM JAMES W | Director | Buy | 31,332 |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 10,580 |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 54,582 |
| 2024-03-21 | Thunen Shelley B | See remarks | Award | 27,000 |
| 2024-03-21 | Guerard Frederic | Director | Award | 23,571 |
| 2024-03-21 | Guerard Frederic | Director | Award | 30,897 |
| 2024-03-21 | Guerard Frederic | Director | Award | 27,000 |
| 2024-03-21 | Drapkin Kimberlee C | Director | Award | 27,000 |
| 2024-03-21 | Olsson Shawn | Chief Commercial Officer | Award | 105,000 |
| 2024-03-21 | Olsson Shawn | Chief Commercial Officer | Award | 30,466 |
| 2024-03-21 | Olsson Shawn | Chief Commercial Officer | Award | 50,915 |
| 2024-03-21 | Olsson Shawn | Chief Commercial Officer | Award | 67,974 |
| 2024-03-21 | Odrich Marc | Chief Medical Officer | Award | 105,000 |
| 2024-03-21 | Odrich Marc | Chief Medical Officer | Award | 99,599 |
| 2024-03-21 | Odrich Marc | Chief Medical Officer | Award | 66,472 |
| 2024-03-21 | Schimmelpennink Evert B. | Director | Award | 82,723 |